{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:52:56Z","timestamp":1787003576445,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The electrocardiogram (ECG) represents an essential tool to determine cardiac electrical abnormalities in COVID-19 patients, the effects of anti-SARS-CoV-2 drugs, and potential drug interactions. Smartphone-based heart monitors have increased the spectrum of ECG monitoring however, we are not aware of its reliability in critically ill COVID-19 patients. We aim to evaluate the feasibility and reliability of nurse-performed smartphone electrocardiography for QT interval monitoring in critically ill COVID-19 patients using KardiaMobile-6L compared with the standard 12-lead ECG. An observational comparative study was conducted comparing consecutive KardiaMobile-6L and 12-lead ECG recordings obtained from 20 patients admitted to the intensive care unit with SARS-CoV-2 infection and on invasive mechanical ventilation. The heart rate-corrected QT (QTc) intervals measured by KardiaMobile-6L and 12-lead ECG were compared. In 60 percent of the recordings, QTc intervals measured by KardiaMobile-6L matched those by 12-lead ECG. The QTc intervals measured by KardiaMobile-6 and 12-lead ECG were 428\u2009\u00b1\u200945\u00a0ms and 425\u2009\u00b1\u200935\u00a0ms (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.82), respectively. The former demonstrated good agreement (bias\u2009=\u20092.9\u00a0ms; standard deviation of bias\u2009=\u200929.6\u00a0ms) with the latter, using the Bland\u2013Altman method of measurement agreement. In all but one recording, KardiaMobile-6L demonstrated QTc prolongation. QTc interval monitoring with KardiaMobile-6L in critically ill COVID-19 patients was feasible and demonstrated reliability comparable to the standard 12-lead ECG.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-37688-8","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T17:02:19Z","timestamp":1688662939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients"],"prefix":"10.1038","volume":"13","author":[{"given":"Matilde","family":"Zaballos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Juncos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alvarez-Zaballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Hortal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"issue":"1","key":"37688_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13054-020-03449-6","volume":"25","author":"D Contou","year":"2021","unstructured":"Contou, D. et al. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: No prognostic improvement during the second wave?. Crit Care 25(1), 3. https:\/\/doi.org\/10.1186\/s13054-020-03449-6 (2021).","journal-title":"Crit Care"},{"issue":"1","key":"37688_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13054-020-03098-9","volume":"24","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: A multicenter retrospective study from Wuhan, China. Crit Care 24(1), 394. https:\/\/doi.org\/10.1186\/s13054-020-03098-9 (2020).","journal-title":"Crit Care"},{"key":"37688_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/TCRM.S280079","volume":"17","author":"S Zhou","year":"2021","unstructured":"Zhou, S. et al. Clinical features for severely and critically ill patients with COVID-19 in Shandong: A Retrospective Cohort Study. Ther. Clin. Risk Manag. 17, 9\u201321. https:\/\/doi.org\/10.2147\/TCRM.S280079 (2021).","journal-title":"Ther. Clin. Risk Manag."},{"issue":"4","key":"37688_CR4","doi-asserted-by":"publisher","first-page":"e227970","DOI":"10.1001\/jamanetworkopen.2022.7970","volume":"5","author":"V Conti","year":"2022","unstructured":"Conti, V. et al. Identification of drug interaction adverse events in patients with COVID-19: A systematic review. JAMA Netw Open. 5(4), e227970. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.7970 (2022).","journal-title":"JAMA Netw Open."},{"issue":"18","key":"37688_CR5","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","volume":"75","author":"E Driggin","year":"2020","unstructured":"Driggin, E. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J. Am. Coll. Cardiol. 75(18), 2352\u20132371. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.031 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"37688_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/pace.14247","volume":"44","author":"S Garcia-Zamora","year":"2021","unstructured":"Garcia-Zamora, S. et al. Arrhythmias and electrocardiographic findings in Coronavirus disease 2019: A systematic review and meta-analysis. Pacing Clin. Electrophysiol. 44(6), 1062\u20131074. https:\/\/doi.org\/10.1111\/pace.14247 (2021).","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"8","key":"37688_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.tcm.2020.08.002","volume":"30","author":"AS Manolis","year":"2020","unstructured":"Manolis, A. S. et al. COVID-19 infection and cardiac arrhythmias. Trends Cardiovasc. Med. 30(8), 451\u2013460. https:\/\/doi.org\/10.1016\/j.tcm.2020.08.002 (2020).","journal-title":"Trends Cardiovasc. Med."},{"key":"37688_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jelectrocard.2020.08.007","volume":"62","author":"S Haseeb","year":"2020","unstructured":"Haseeb, S. et al. International Society of Electrocardiology Young Community (ISE-YC). Value of electrocardiography in coronavirus disease 2019 (COVID-19). J. Electrocardiol. 62, 39\u201345. https:\/\/doi.org\/10.1016\/j.jelectrocard.2020.08.007 (2020).","journal-title":"J. Electrocardiol."},{"key":"37688_CR9","unstructured":"https:\/\/www.crediblemeds.org\/ for examples of drugs used in the ICU with risk of prolonging the QT interval."},{"issue":"1","key":"37688_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4037\/ccn2022465","volume":"42","author":"D Schwimer","year":"2022","unstructured":"Schwimer, D., Al-Zaiti, S. & Beach, M. Improving corrected QT interval monitoring in critical care units: A single center report. Crit. Care Nurse 42(1), 33\u201343. https:\/\/doi.org\/10.4037\/ccn2022465 (2022).","journal-title":"Crit. Care Nurse"},{"issue":"21","key":"37688_CR11","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.118.033943","volume":"138","author":"AS Vink","year":"2018","unstructured":"Vink, A. S. et al. Determination and Interpretation of the QT Interval. Circulation 138(21), 2345\u20132358. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.033943 (2018).","journal-title":"Circulation"},{"key":"37688_CR12","doi-asserted-by":"publisher","unstructured":"Chu, D. K., Akl, E. A., Duda, S., Solo, K., Yaacoub, S., Sch\u00fcnemann, H. J.; COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis. Lancet 395(10242), 1973\u20131987. https:\/\/doi.org\/10.1016\/S0140-6736(20)31142-9 (2020).","DOI":"10.1016\/S0140-6736(20)31142-9"},{"issue":"2","key":"37688_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/jamasurg.2020.6643","volume":"156","author":"M Klompas","year":"2021","unstructured":"Klompas, M., Baker, M. & Rhee, C. What is an aerosol-generating procedure?. JAMA Surg. 156(2), 113\u2013114. https:\/\/doi.org\/10.1001\/jamasurg.2020.6643 (2021).","journal-title":"JAMA Surg."},{"issue":"7","key":"37688_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/jce.12976","volume":"27","author":"P Garabelli","year":"2016","unstructured":"Garabelli, P. et al. Comparison of QT interval readings in normal sinus rhythm between a smartphone heart monitor and a 12-lead ECG for healthy volunteers and inpatients receiving sotalol or dofetilide. J. Cardiovasc. Electrophysiol. 27(7), 827\u2013832. https:\/\/doi.org\/10.1111\/jce.12976 (2016).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"37688_CR15","unstructured":"Cardiovascular, Featured, Food & Drug Administration (FDA), Regulatory\/Compliance Tagged With: Alivecor, Coronavirus, Covid-19, FDA. https:\/\/www.massdevice.com\/fda-allows-use-of-alivecors-kardia-device-for-covid-19-patients\/. Accessed June 2022."},{"issue":"6","key":"37688_CR16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03.024","volume":"95","author":"JR Giudicessi","year":"2020","unstructured":"Giudicessi, J. R., Noseworthy, P. A., Friedman, P. A. & Ackerman, M. J. Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19). Mayo Clin. Proc. 95(6), 1213\u20131221. https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.024 (2020).","journal-title":"Mayo Clin. Proc."},{"key":"37688_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ehjdh\/ztab034","author":"RL Shah","year":"2021","unstructured":"Shah, R. L. et al. Antiarrhythmic drug loading at home using remote monitoring: A virtual feasibility study during COVID-19 social distancing. Eur. Heart J. Digit. Health https:\/\/doi.org\/10.1093\/ehjdh\/ztab034 (2021).","journal-title":"Eur. Heart J. Digit. Health"},{"issue":"16","key":"37688_CR18","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1001\/jama.289.16.2120","volume":"289","author":"SM Al-Khatib","year":"2003","unstructured":"Al-Khatib, S. M., LaPointe, N. M., Kramer, J. M. & Califf, R. M. What clinicians should know about the QT interval. JAMA 289(16), 2120\u20132127. https:\/\/doi.org\/10.1001\/jama.289.16.2120 (2003).","journal-title":"JAMA"},{"issue":"9","key":"37688_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.ajic.2022.01.003","volume":"50","author":"MM Alshamrani","year":"2022","unstructured":"Alshamrani, M. M. et al. Risk of COVID-19 in healthcare workers working in intensive care setting. Am. J. Infect. Control 50(9), 988\u2013993. https:\/\/doi.org\/10.1016\/j.ajic.2022.01.003 (2022).","journal-title":"Am. J. Infect. Control"},{"issue":"5","key":"37688_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/jce.12634","volume":"26","author":"ZC Haberman","year":"2015","unstructured":"Haberman, Z. C. et al. Wireless smartphone ECG enables large-scale screening in diverse populations. J. Cardiovasc. Electrophysiol. 26(5), 520\u2013526. https:\/\/doi.org\/10.1111\/jce.12634 (2015).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"37688_CR21","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.ijcha.2020.100644","volume":"30","author":"NT Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez, N. T. et al. QT interval measurement with portable device during COVID-19 outbreak. Int. J. Cardiol. Heart Vasc. 30, 100644. https:\/\/doi.org\/10.1016\/j.ijcha.2020.100644 (2020).","journal-title":"Int. J. Cardiol. Heart Vasc."},{"issue":"1","key":"37688_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5334\/gh.916","volume":"16","author":"C Minguito-Carazo","year":"2021","unstructured":"Minguito-Carazo, C. et al. QT interval monitoring with handheld heart rhythm ECG device in COVID-19 patients. Glob. Heart. 16(1), 42. https:\/\/doi.org\/10.5334\/gh.916 (2021).","journal-title":"Glob. Heart."},{"issue":"2","key":"37688_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10840-021-00989-x","volume":"63","author":"HH Liu","year":"2022","unstructured":"Liu, H. H. et al. Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic. J. Interv. Card. Electrophysiol. 63(2), 345\u2013356. https:\/\/doi.org\/10.1007\/s10840-021-00989-x (2022).","journal-title":"J. Interv. Card. Electrophysiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37688-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37688-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37688-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T17:02:22Z","timestamp":1688662942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37688-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37688"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-37688-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"assertion":[{"value":"25 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10985"}}